D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -59.62% -76.11% -100.00%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -59.62% -76.11% -100.00%
Cost of Revenue 46.04% 41.21% 43.56% 38.66% 23.22%
Gross Profit -46.04% -42.33% -46.13% -47.25% -25.63%
SG&A Expenses 65.00% 67.22% 86.15% 70.88% 51.48%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 51.21% 48.00% 54.09% 46.41% 29.82%
Operating Income -51.21% -48.87% -56.21% -53.26% -31.76%
Income Before Tax -34.11% -33.71% -45.27% -45.52% -33.58%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -34.11% -33.71% -45.27% -45.52% -33.58%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -34.11% -33.71% -45.27% -45.52% -33.58%
EBIT -51.21% -48.87% -56.21% -53.26% -31.76%
EBITDA -50.58% -48.25% -55.61% -53.17% -31.98%
EPS Basic 1.58% 5.15% 0.21% -8.52% -7.10%
Normalized Basic EPS 1.59% 5.17% 0.20% -8.51% -7.10%
EPS Diluted 1.58% 5.15% 0.21% -9.00% -7.10%
Normalized Diluted EPS 1.59% 5.17% 0.20% -8.51% -7.10%
Average Basic Shares Outstanding 36.26% 40.99% 45.57% 34.10% 24.72%
Average Diluted Shares Outstanding 36.26% 40.99% 45.57% 34.10% 24.72%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings